Successful canakinumab treatment for activated innate response in idiopathic Castleman's disease with multiple heterozygous MEFV exon 2 variants
Endo, Yushiro, Koga, Tomohiro, Umeda, Masataka, Furukawa, Kaori, Takenaka, Motoi, Kawakami, AtsushiVolume:
219
Journal:
Clinical Immunology
DOI:
10.1016/j.clim.2020.108547
Date:
October, 2020
File:
PDF, 332 KB
2020